Treatment of viral infections continues to be elusive owing to the variance in virus structure together with their ability to rapidly change and become resistant. In recent years, viral infections have emerged as an eminent global public health problem. The patent describes a molecule which can interact with the virus making it less capable of entering a human cell. Alternatively, the molecule can also interact with human cells making them more resistant to a virus entering the cell or replicating within the cell as compared to an untreated cell. Patented anti-viral agents include cationic polyamines active against a broad spectrum of viruses, including Dengue, H1N1, SARS, influenza and coronaviruses.
Title – Cationic polyamines for treatment of viruses
Patent holder: IBM
Patent Number – 9682100
Link – https://patents.google.com/patent/US9682100B2/en